Literature DB >> 6617044

Nomogram for estimating creatinine clearance.

T D Bjornsson, D M Cocchetto, F X McGowan, C P Verghese, F Sedor.   

Abstract

Several methods have been published for estimating creatinine clearance from serum creatinine concentrations. Such estimates of creatinine clearance are widely used for dosage adjustments of drugs which are primarily eliminated through the kidneys in patients with reduced renal function. Most of these methods involve the use of equations, requiring a few steps of calculations. A simple and easy-to-use nomogram is presented for estimating creatinine clearance from serum creatinine concentration, plus the age, sex, and bodyweight of the individual patient. This nomogram is based on the linear relationship between creatinine clearance and the reciprocal value of the serum creatinine concentration, where the slope of this relationship is determined by the rate of creatinine production. The rate of creatinine production, however, is related to age, sex, and bodyweight. These physical characteristics are therefore used to scale the slopes of the relationships between creatinine clearance and serum creatinine concentration. The validity of the nomogram was tested in 50 consecutive hospitalised patients for which creatinine clearance was measured. There was an excellent correlation (r = 0.903) between predicted and observed creatinine clearance values.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617044     DOI: 10.2165/00003088-198308040-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  22 in total

1.  Relationship between endogenous 24-hour creatinine clearance and serum creatinine concentration in patients with chronic renal disease.

Authors:  P EFFERSOE
Journal:  Acta Med Scand       Date:  1957-02-02

2.  Creatinine excretion in renal failure.

Authors:  R GOLDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

3.  Creatin and creatinin.

Authors:  E Mellanby
Journal:  J Physiol       Date:  1908-02-28       Impact factor: 5.182

Review 4.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

5.  Rapid evaluation of creatinine clearance.

Authors:  J Kampmann; K Siersbaek-Nielsen; M Kristensen; J M Hansen
Journal:  Acta Med Scand       Date:  1974-12

6.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

7.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency.

Authors:  G E Mawer; S B Lucas; B R Knowles; R M Stirland
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

8.  Prediction of creatinine clearance from serum creatinine concentration based on lean body mass.

Authors:  T Hallynck; H H Soep; J Thomis; J Boelaert; R Daneels; J P Fillastre; F De Rosa; E Rubinstein; M Hatala; J Spousta; L Dettli
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

9.  THE SYNTHESIS, STORAGE, AND EXCRETION OF CREATINE, CREATININE, AND GLYCOCYAMINE IN PROGRESSIVE MUSCULAR DYSTROPHY AND THE EFFECTS OF CERTAIN HORMONES ON THESE PROCESSES.

Authors:  C L Hoagland; H Gilder; R E Shank
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

10.  Creatine and muscular dystrophy. Relationship of creatine-creatinine metabolism to diet and drugs.

Authors:  N BOURDAKOS; S WOLF
Journal:  Arch Neurol       Date:  1962-06
View more
  11 in total

1.  Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects.

Authors:  J B Lecaillon; J P Dubois; H Coppens; T Darragon; W Theobald; G Reumond; H Beck
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

2.  Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients.

Authors:  I W Taylor; L F Chasseaud; T Taylor; I James; G Dorf; A Darragh
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 3.  Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations.

Authors:  T D Bjornsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

4.  The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate.

Authors:  D G Waller; J S Fleming; B Ramsey; J Gray
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

5.  Renal elimination of amikacin and the aging process.

Authors:  M Ducher; P Maire; C Cerutti; Y Bourhis; F Foltz; P Sorensen; R Jelliffe; J P Fauvel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Jon J Snyder; Robert N Foley; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

7.  The effect of age on the pharmacokinetics of enoxacin.

Authors:  B R Dobbs; L R Gazeley; A J Campbell; I R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Nomogram for drug dosage adjustment in patients with renal failure.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

9.  Pharmacokinetics of ranitidine in critically ill patients.

Authors:  K F Ilett; R L Nation; R Tjokrosetio; W R Thompson; T E Oh; P D Cameron
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

10.  Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients.

Authors:  M J Dooley; S Singh; D Rischin
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.